Global Cell Therapy Technology Market Analysis/Research Report 2022: A $33.59 Billion Market by 2027 - Opportunities in the Emergence of iPSCs as an Alternative to ESCs in Technologies - ResearchAndMarkets.com

·6 min read

DUBLIN, May 24, 2022--(BUSINESS WIRE)--The "Cell Therapy Technologies Market Research Report by Product (Consumables, Equipment, and Systems & Software), Process, Cell Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Cell Therapy Technologies Market size was estimated at USD 14.88 billion in 2021, USD 17.02 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.53% to reach USD 33.59 billion by 2027.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ceramic Textile Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. I

t provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate.

The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Cumulative Impact of COVID-19:

The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Company Usability Profiles:

  • Beckman Coulter, Inc.

  • Becton, Dickinson and Company

  • Ge Healthcare

  • Lonza Group

  • Merck KGaA

  • Miltenyi Biotec GmbH

  • Sartorius

  • Stemcell Technologies

  • Terumo Bct, Inc.

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Limitations

1.7. Assumptions

1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective

2.2. Determine: Research Design

2.3. Prepare: Research Instrument

2.4. Collect: Data Source

2.5. Analyze: Data Interpretation

2.6. Formulate: Data Verification

2.7. Publish: Research Report

2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.1.1. Growing incidence of chronic diseases and infections globally

5.1.1.2. Rising GMP certifications for cell therapy production facilities

5.1.1.3. Surge in government initiatives through investments in cell-based research

5.1.2. Restraints

5.1.2.1. Relatively high costs involved and reduced success rate

5.1.3. Opportunities

5.1.3.1. Ongoing focus on personalized medicine

5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies

5.1.4. Challenges

5.1.4.1. Dearth of skilled professional and survival difficulty of small players and new entrants

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Cell Therapy Technologies Market, by Product

6.1. Introduction

6.2. Consumables

6.3. Equipment

6.3.1. Cell Processing Equipment

6.3.2. Single-Use Equipment

6.4. Systems & Software

7. Cell Therapy Technologies Market, by Process

7.1. Introduction

7.2. Cell Preservation, Distribution, and Handling

7.3. Cell Processing

7.4. Process Monitoring and Quality Control

8. Cell Therapy Technologies Market, by Cell Type

8.1. Introduction

8.2. Animal Cells

8.3. Human Cells

8.3.1. Differentiated Cells

8.3.2. Stem Cells

9. Cell Therapy Technologies Market, by End User

9.1. Introduction

9.2. Life Science Research Companies

9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

10.1. Introduction

10.2. Argentina

10.3. Brazil

10.4. Canada

10.5. Mexico

10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

11.1. Introduction

11.2. Australia

11.3. China

11.4. India

11.5. Indonesia

11.6. Japan

11.7. Malaysia

11.8. Philippines

11.9. Singapore

11.10. South Korea

11.11. Taiwan

11.12. Thailand

12. Europe, Middle East & Africa Cell Therapy Technologies Market

12.1. Introduction

12.2. France

12.3. Germany

12.4. Italy

12.5. Netherlands

12.6. Qatar

12.7. Russia

12.8. Saudi Arabia

12.9. South Africa

12.10. Spain

12.11. United Arab Emirates

12.12. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix

13.1.1. Quadrants

13.1.2. Business Strategy

13.1.3. Product Satisfaction

13.2. Market Ranking Analysis

13.3. Market Share Analysis, By Key Player

13.4. Competitive Scenario

13.4.1. Merger & Acquisition

13.4.2. Agreement, Collaboration, & Partnership

13.4.3. New Product Launch & Enhancement

13.4.4. Investment & Funding

13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

For more information about this report visit https://www.researchandmarkets.com/r/wmm6ma

View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005869/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting